Align Technology | ALGN - Ordinary Share Capital


Align Technology reported $71.75M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
3M USD 530.28M 946K Dec/2025
Align Technology USD 71.75M 736K Dec/2025
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Bruker USD 151.94M 225K Dec/2025
Cardinal Health USD 238M 1000K Sep/2025
Charles River Laboratories USD 49.22M 2K Dec/2025
Cooper Companies USD 195.1M 3.71M Dec/2025
CVS Health USD 1.27B 1000K Dec/2025
Danaher USD 706.9M 600K Dec/2025
Dentsply International USD 199.5M 196.5M Sep/2025
Dexcom USD 384.8M 5.2M Dec/2025
Henry Schein USD 115.77M 2.8M Dec/2025
Idexx Laboratories USD 79.85M 154K Dec/2025
Insulet USD 70.35M 1000 Dec/2025
Integra LifeSciences USD 77.89M 34K Dec/2025
IQVIA Holdings USD 169.6M 700K Dec/2025
Masimo USD 52.1M 1000K Dec/2025
McKesson USD 280M 156M Dec/2025
Mettler Toledo International USD 20.43M 170.6K Dec/2025
Revvity USD 113.38M 2.7M Dec/2025
Solventum Corp USD 173.49M 51.34K Dec/2025
Stryker USD 382.4M 93K Dec/2025
Teleflex USD 44.19M 1000 Dec/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
Veeva Systems USD 164.38M 39K Dec/2025
Waters USD 98.08M 38.55M Dec/2025
Zimmer Biomet Holdings USD 198.18M 18.44K Dec/2025
Zoetis USD 424.93M 16.54M Dec/2025